Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Julie Goodman to Risk Assessment

This is a "connection" page, showing publications Julie Goodman has written about Risk Assessment.

 
Connection Strength
 
 
 
0.766
 
  1. Goodman JE, Boyce CP, Pizzurro DM, Rhomberg LR. Strengthening the foundation of next generation risk assessment. Regul Toxicol Pharmacol. 2014 Feb; 68(1):160-70.
    View in: PubMed
    Score: 0.245
  2. Dodge DG, Engel AM, Prueitt RL, Peterson MK, Goodman JE. US EPA's TSCA risk assessment approach: a case study of asbestos in automotive brakes. Inhal Toxicol. 2021 Aug-Dec; 33(9-14):295-307.
    View in: PubMed
    Score: 0.106
  3. Zu K, Pizzurro DM, Lewandowski TA, Goodman JE. Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts. Regul Toxicol Pharmacol. 2017 Oct; 89:83-94.
    View in: PubMed
    Score: 0.079
  4. Lynch HN, Loftus CT, Cohen JM, Kerper LE, Kennedy EM, Goodman JE. Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer. Regul Toxicol Pharmacol. 2016 Dec; 82:53-93.
    View in: PubMed
    Score: 0.075
  5. Goodman JE, Seeley M, Mattuck R, Thakali S. Do group responses mask the effects of air pollutants on potentially sensitive individuals in controlled human exposure studies? Regul Toxicol Pharmacol. 2015 Apr; 71(3):552-64.
    View in: PubMed
    Score: 0.066
  6. Goodman JE, Peterson MK, Bailey LA, Kerper LE, Dodge DG. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer. Regul Toxicol Pharmacol. 2014 Feb; 68(1):8-15.
    View in: PubMed
    Score: 0.061
  7. Goodman JE, Dodge DG, Bailey LA. A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. Regul Toxicol Pharmacol. 2010 Nov; 58(2):308-22.
    View in: PubMed
    Score: 0.048
  8. Cox LA, Goodman JE, Engel AM. Chronic inflammation, Adverse Outcome Pathways, and risk assessment: A diagrammatic exposition. Regul Toxicol Pharmacol. 2020 Jul; 114:104663.
    View in: PubMed
    Score: 0.024
  9. Lynch HN, Goodman JE, Tabony JA, Rhomberg LR. Systematic comparison of study quality criteria. Regul Toxicol Pharmacol. 2016 Apr; 76:187-98.
    View in: PubMed
    Score: 0.018
  10. Petito Boyce C, Goodman JE, Sax SN, Loftus CT. Providing perspective for interpreting cardiovascular mortality risks associated with ozone exposures. Regul Toxicol Pharmacol. 2015 Jun; 72(1):107-16.
    View in: PubMed
    Score: 0.017
  11. Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. Regul Toxicol Pharmacol. 2014 Jun; 69(1):22-40.
    View in: PubMed
    Score: 0.016
  12. Bailey LA, Goodman JE, Beck BD. Proposal for a revised Reference Concentration (RfC) for manganese based on recent epidemiological studies. Regul Toxicol Pharmacol. 2009 Dec; 55(3):330-9.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)